(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BETTER CELLS FOR BETTER THERAPIES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BETTER CELLS FOR BETTER THERAPIES

ST13

US500000086984029

Class

42

Filing

86984029

Registration

5556215

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

12/06/2024

Trademark type

Word

Nice classes

42

Filing date

01/08/2016

Registration date

09/04/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/06/2024

Last transaction

12/06/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/11/2016

First use in commerce

01/11/2016

Drawing code

4

Owner type

03

Owner location

San Diego, CA

Examiner

LAVACHE, LINDA

Current location

Historical data usage

Holders and representatives

Holders

Fate Therapeutics, Inc.

Representatives

Jared M. Barrett SEED IP LAW GROUP LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Medical and clinical research and development for others in the field of stem cells; consulting services in the field of stem cell therapy researchdisease model systems researchdrug discovery and development; medical laboratory research; researchscientific research; medical and scientific researchconducting pre-clinical and clinical trials

Publications

History of USPTO decisions and trademark events.

37 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/06/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/06/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/05/2024

E815

TEAS SECTION 8 & 15 RECEIVED

06/26/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/04/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

09/04/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/01/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/31/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/30/2018

DPCC

DIVISIONAL PROCESSING COMPLETE

07/30/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/30/2018

IUAF

USE AMENDMENT FILED

07/10/2018

DRRR

DIVISIONAL REQUEST RECEIVED

07/10/2018

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

07/10/2018

EISU

TEAS STATEMENT OF USE RECEIVED

07/10/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/12/2018

EX2G

SOU EXTENSION 2 GRANTED

01/10/2018

EXT2

SOU EXTENSION 2 FILED

01/10/2018

EEXT

SOU TEAS EXTENSION RECEIVED

01/10/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/14/2017

EX1G

SOU EXTENSION 1 GRANTED

06/12/2017

EXT1

SOU EXTENSION 1 FILED

06/12/2017

EEXT

SOU TEAS EXTENSION RECEIVED

06/12/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/10/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/15/2016

PUBO

PUBLISHED FOR OPPOSITION

11/15/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/26/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/03/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/29/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/28/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/28/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/26/2016

GNRT

NON-FINAL ACTION E-MAILED

04/26/2016

CNRT

NON-FINAL ACTION WRITTEN

04/26/2016

DOCK

ASSIGNED TO EXAMINER

04/25/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/15/2016

NWAP

NEW APPLICATION ENTERED

01/12/2016

Continuous trademark protection

Get notified about every new filing that threatens BETTER CELLS FOR BETTER THERAPIES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.